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TDP-43 is an essential RNA-binding protein forming aggregates in almost all cases of
sporadic amyotrophic lateral sclerosis (ALS) and many cases of frontotemporal lobar
dementia (FTLD) and other neurodegenerative diseases. TDP-43 consists of a folded
N-terminal domain with a singular structure, two RRM RNA-binding domains, and
a long disordered C-terminal region which plays roles in functional RNA regulatory
assemblies as well as pernicious aggregation. Evidence from pathological mutations
and seeding experiments strongly suggest that TDP-43 aggregates are pathologically
relevant through toxic gain-of-harmful-function and/or harmful loss-of-native-function
mechanisms. Recent, but not early, microscopy studies and the ability of TDP-43
aggregates to resist harsh treatment and to seed new pathological aggregates in vitro
and in cells strongly suggest that TDP-43 aggregates have a self-templating, amyloid-like
structure. Based on the importance of the Gln/Asn-rich 341–367 residue segment for
efficient aggregation of endogenous TDP-43 when presented as a 12X-repeat and
extensive spectroscopic and computational experiments, we recently proposed that this
segment adopts a beta-hairpin structure that assembles in a parallel with a beta-turn
configuration to form an amyloid-like structure. Here, we propose that this conformer is
stabilized by an especially strong class of hypercooperative hydrogen bonding unique
to Gln and Asn sidechains. The clinical existence of this conformer is supported
by very recent LC-MS/MS characterization of TDP-43 from ex vivo aggregates,
which show that residues 341–367 were protected in vivo from Ser phosphorylation,
Gln/Asn deamidation and Met oxidation. Its distinct pattern of SDS-PAGE bands allows
us to link this conformer to the exceptionally stable seed of the Type A TDP-43
proteinopathy.
Keywords: pathological amyloids, transitive response DNA-bonding protein 43 kDa (TDP-43), hnRNPs, hyperstable
H-bonds, amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration, protein misfolding and disease
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a rare, paralyzing mortal disease which involves the death
of motor neurons, leading to progressive muscle atrophy and death (Kiernan et al., 2011). In 1991,
ubiquitinated aggregates were detected in the motor neurons of patients affected by ALS (Leigh
et al., 1991). In 2006, these aggregates were identified as ubiquitinated and polyphosphorylated
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TDP-43 (Arai et al., 2006; Neumann et al., 2006), an essential,
well-conserved protein involved in RNA splicing, transport and
translation regulation (Buratti and Baralle, 2012). C-terminal
fragments of 35 kD and 25 kD were also observed. Soon
afterwards, many mutations in TDP-43 genetically linked
to ALS and frontotemporal lobar dementia (FTLD) were
discovered, as recently reviewed (Buratti, 2016). These mutations
and the observation of TDP-43 aggregates in the motor
neurons of practically all ALS and many FTLD patients
are evidence of TDP-43’s central role in this spectrum of
neuromuscular/dementia pathologies (Kiernan et al., 2011).
From the point of view of the protein architecture, it is fascinating
that almost all of these mutations are located in the C-terminal
region (Pesiridis et al., 2009). In concert with mutational,
functional and dysfunctional results from in vitro and in vivo
studies, an advanced knowledge of TDP-43’s structure is key to
understand its roles in physiological and pathological processes,
which are summarized in Figure 1A, that could eventually guide
the development of prophylactics and treatments.
TDP-43 Contains Three Folded Domains
and an Intrinsically Unfolded C-Terminal
Region
Due to its intrinsic high-aggregation propensity, it has been
impossible to solve the full structure of TDP-43. However,
according to all the evidence gathered in recent years, TDP-43
consists of a folded N-terminal domain, two folded RRM
domains and an intrinsically disordered C-terminal region
(Figure 1B). The N-terminal domain has a singular tertiary
structure, contains two negatively charged loops (Qin et al.,
2014; Mompeán et al., 2016c) and is important for TDP-43’s
physiological and pathological functions (Zhang et al., 2013;
Budini et al., 2015; Sasaguri et al., 2016). In particular, the
N-terminal domain is essential for the efficient capture of
endogenous TDP-43 molecules into aggregates and induces a
loss-of-function phenotype in cultured neuronal cells (Budini
et al., 2015).
The RRM domains bind UG-rich segments of RNA and
are essential for TDP-43’s physiological functions (Ayala et al.,
2005; Lukavsky et al., 2013). Interestingly, both the N-terminal
domain and the first RRM domain are stable (with TM’s close
to 50◦C; Kuo et al., 2009; Wang et al., 2013; Mompeán et al.,
2016c), but the second RRM domain is much more stable
(TM = >85◦C; Kuo et al., 2009; Wang et al., 2013). Although
the physiological relevance of these differences are unknown;
here we speculatively propose that the second RRM domain’s
high stability could aid the proper presentation of the nuclear
export signal present within this domain (residues 238–250)
or chaperone residues 246–255 which tend to form amyloid
and hydrogels (Wang et al., 2013; Saini and Chauhan, 2014).
Among the similarities and differences between the two domains
involved in nucleic acids, RRM2 adopts an atypical RRM-fold
with an additional beta-strand that could mediate RRM2-RRM2
protein interactions.
The preferred binding motif of these RRMs is represented
by single-stranded UG-rich regions/repeats that are recognized
with high affinity (Buratti and Baralle, 2011; Polymenidou
et al., 2011; Tollervey et al., 2011). Both RRMs contribute
to nucleic acid binding, with RRM1 specifically recognizing
one GU repeat. RRM2 recognizes one UG repeat and binds
to additional nucleotides nonspecifically. Thus, the emerging
binding consensus sequence is 5′-N(N)GUGN(N)UGN-3′.
A unique feature of the TDP-43—RNA complex is the reversed
binding of the UG-rich RNA with the 5′end being bound to
RRM1, rather than RRM2 (Lukavsky et al., 2013). This is in
contrast to all other tandem RRMs characterized to date and
might explain some peculiarities of TDP-43 functions. In fact,
whilst TDP-43 binding to UG-rich RNA through RRM1 shows
a very clear correlation between binding and inhibitory splicing
function, this does not occur for RRM2 where alanine mutations
in its recognition sites have only a small effect on TDP-43’s
overall RNA binding affinity. Nevertheless, these interactions
are functionally important and are required for the splicing
function of TDP-43. Thus, the role of RRM2 could be to
orient the UG-rich RNA for productive TDP-43 dimerization on
pre-mRNA target sites.
Another remarkable feature of the second RRM domain is
that it carries an overall charge of −9 at pH 7. In contrast,
the first RRM domain has a net positive charge (Figure 1B).
This difference might account in part for the second RRM
domain’s weaker RNA binding as its negative charges could
electrostatically repel longer RNA oligos. In this respect, it is
interesting to note that the second RRM domain binds shorter
RNA oligos better than longer ones (Kuo et al., 2009).
In contrast to the N-terminal and RRM domains, the
C-terminal region is intrinsically disordered (Lim et al., 2016).
It is remarkably poor in charged residues (Figure 1B), which is
related to its meager solubility (Mompeán et al., 2016a). It can be
divided into four sub-regions; namely a Gly, Aromatic, Ser-rich
(GaroS) segment, a hydrophobic segment, a Gln/Asn (Q/N)-
rich segment, and a second GaroS rich segment. The GaroS
segments resemble the [G,S]Y[G,S] motifs of the intrinsically
disordered region of ‘‘Fused in Sarcoma’’ (FUS), an RNA-binding
protein that like TDP-43 is also aberrantly aggregated in ALS
and FTLD pathologies. These motifs were proposed to endow
TDP-43 and FUS with the ability to participate in RNA
granules and form hydrogels (Kato et al., 2012). Although
these segments do not resemble those of pathological amyloids,
their ability to increase the local concentration of TDP-43
within RNA granules may boost the probability that the
aberrant oligomers might form, along the lines of the model
recently proposed for FUS (Patel et al., 2015), particularly
in the context of some disease-related mutations (Lim et al.,
2016).
These considerations raise several hypotheses for the origin
of the pathology that involve a crucial role for interdomain
contacts to eventually trigger the pathological aggregation
process. In this respect, Zhang et al. (2013) have modeled the
possible interaction between the N-terminal and C-terminal
domains to regulate proper homodimerization of TDP-43 while
Mackness et al. (2014) have investigated the different potential
folding intermediates in the RRM1 and RRM2 domains. In
addition, Wang et al. (2013) have shown that TDP-43 without
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FIGURE 1 | Native function, pathological aggregation and structure of TDP-43. (A) TDP-43 (green ellipses) performs vital physiological roles (green) in
pre-mRNA splicing, microRNA processing, transcriptional regulation and post-transcriptional autoregulation of its own expression, mRNA transport, stability and
translational regulation (through stress granule formation) before being degraded or shuttling back to the nucleus. However, the chance formation of aberrant
conformers, which could be facilitated by mutation (red asterisk), aberrant cleavage, cytoplasmic mislocalization, aging and/or high local TDP-43 concentration in
stress granules, may lead to the formation of a pathological amyloid-like aggregate. We propose that this aggregate consists of beta hairpins formed by residues
341–367 (purple) and is stabilized by hyper-stable inter-molecular hydrogen bonds. In this schematic diagram, DNA is represented by a double blue line, RNA is
shown as a curved blue line and other proteins, the nuclear membrane and the ribosome are colored gray. (B) The domain composition and 3D structures of the
N-terminal and RRM domains of TDP-43, as well as plausible, partially populated helical and quasi-amyloid conformers of the disordered C-terminal regions are
shown. The net charge of the different domains, segments and the C-terminal region are indicated. The lower portion of the figure shows the sequence of the linker
(residues 263–272), and the C-terminal subregions: G, S, aromatic-rich segment (GaroS1; 273–317), hydrophobic (318–340), Q/N-rich (341–367) and second GaroS
region (368–414). Residues are colored blue (KHR), red (E, D), green (G, S, F, Y, W), purple (N, Q) or written in bold (aliphatics).
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the C-terminal region can form a homodimer primarily via
N-terminal domain contacts.
Although the previously mentioned genetic evidence and
these biochemical data strongly link TDP-43’s C-terminal region
to pathology, many aspects of this issue still remain to be
addressed. For example, there is still a very open debate regarding
the amyloid vs. amorphous nature of these aggregates, their
atomic level structure, and what interactions could stabilize
them. In this Perspective, we shall put together diverse results
from the literature to address these points and advance a
working hypothesis that an amyloid-like conformer, composed
of beta-hairpins formed by residues 341–357, is the relevant
pernicious structure for TDP-43 Type A proteinopathies.
TDP-43 can Form Amyloid-Like Fibrils
which Seem to be Pathologically Relevant
One important and long-standing issue is whether the TDP-43
aggregates seen in diseased tissues are amyloid-like or not.
First, it has to be acknowledged that early studies generally
found that TDP-43 in cell inclusions from ex vivo tissues
did not bind amyloid specific dyes like Thioflavin S or show
much fibril formation when examined by immunostaining and
optical microscopy (Cairns et al., 2007; Neumann et al., 2007).
Furthermore, when TDP-43 is expressed in bacteria and purified
from inclusion bodies (Capitini et al., 2014) or expressed in
yeast (Johnson et al., 2008) no evidence for amyloid formation
was detected. Moreover, TDP-43 produced from human cells or
E. coli did not bind Thioflavin T or Congo Red, although it did
form highly cytotoxic oligomers (Fang et al., 2014).
In contrast, several studies found that short peptides derived
from TDP-43’s second RRM domain and C-terminal region
adopt fibril structures that bind amyloid-specific dyes (Chen
et al., 2010; Guo et al., 2011; Saini and Chauhan, 2011, 2014; Jiang
et al., 2013; Mompeán et al., 2014; Sun et al., 2014; Zhu et al.,
2014).
Finally, even middle-of-the-road positions have been
described. For example, Wang et al. (2013) found that
C-terminal truncated forms of TDP-43 can adopt well defined
fibril structure which nonetheless does not bind amyloid specific
dyes or antibodies.
Of course, in most cases these studies’ relevance for human
pathology still needs to be demonstrated. It has to be taken
in consideration, in fact, that TDP-43 is not naturally present
in lower organisms and therefore its conformation could
be altered by diverse in vivo environments. Likewise, the
different context of isolated polypeptide segments vs. their
presence within the complete protein has to be considered.
Nonetheless, studies of ex vivo patient tissues using higher
resolution immuno-gold labeling and electron microscopy
did uncover solid evidence for amyloid-like fibrils formed
by TDP-43 in ALS/FTLD affected neurons (Thorpe et al.,
2008) as well as cells affected by other neurodegenerative
diseases (Lin and Dickson, 2008). More recently, an optical
microscopy study using Thioflavin S and optical microscopy
has reported evidence for amyloid formation by TDP-43
in 30% of ALS patients (Robinson et al., 2013). Finally,
upon treating tissues to remove background due to lipid
autofluorescence, TDP-43 amyloid-like structures could be
detected by Thioflavin S fluorescence in the relevant tissues
of most patients with ALS or FTLD (Bigio et al., 2013). In
conclusion, these results are good evidence that TDP-43 in
patients can form amyloid-like fibrils that are pathologically
relevant.
Hyperphosphorylation of TDP-43
One key hallmark of TDP-43 aggregates is hyperphosphorylation
(Arai et al., 2006; Buratti and Baralle, 2012), and antibodies
raised against specific phosphoserines enabled the identification
of phosphorylated S409 and S410 as characteristic signatures
of pathological TDP-43 aggregates (Neumann et al., 2009).
These negatively charged phosphates seem to decrease the
protein’s aggregation (Brady et al., 2011; Li et al., 2011) and
phosphorylation appears to occur after aggregation in vivo as the
cell attempts to solubilize and degrade the inclusions.
Additional phosphorylation sites were identified utilizing a
set of specific antibodies (Hasegawa et al., 2008) and mass
spectrometry (Kametani et al., 2009). Most phosphorylated
residues (18 of 29) are in the C-terminal region, including
S342, S347 and S350 in the Q/N-rich subregion. More recently,
this laboratory has also analyzed TDP-43 aggregates from two
ex vivo ALS brains (Kametani et al., 2016). Remarkably, they
found 13 phosphorylation sites in one brain and 15 sites in
the second. By comparing these results to those obtained using
soluble TDP-43 (Kametani et al., 2009), it is clear that some
serines; namely S342, S347, and S350, seem to be hidden from
kinase and thus protected from phosphorylation in the context
of the pathological inclusions. This observation is particularly
important as it may give a clue about the location of the
aggregation core.
The Formation of a Helix in the
Hydrophobic C-Terminal Segment Could
Modulate Toxic Aggregate Formation
The relevance of the hydrophobic and Q/N-rich segments to
TDP-43 aggregation was demonstrated by Jiang et al. (2013) who
observed that the C. elegans homolog of TDP-43, which lacks
these segments, is much less prone to aggregation.
The hydrophobic stretch has a very weak tendency to form
helix in aqueous solution, as evidenced by very small 1Hα, 13Cα
conformational chemical shifts and a lack of 1HNi-1HNi+1,i+3,i+4
NOES (Mompeán et al., 2015); nonetheless, a significant amount
of helix does form in the presence of TFE or DPC micelles (Jiang
et al., 2013; Lim et al., 2016). These are important results as
pathological amyloid formation is often characterized by a loss
of native helix in favor of a gain in beta structure. In agreement
with these findings, evidence for a helix to beta conformational
conversion was found in this hydrophobic segment (Jiang et al.,
2013).
Our own recent results (Budini et al., 2012; Mompeán et al.,
2014, 2015) also point to the Q/N-rich segment as being very
important for TDP-43 aggregation and amyloid formation.
Moreover, the recent mass-spectrometry/proteolysis study of
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TDP-43 from ex vivo brains of two ALS patients provides insight
into the relative importance of the hydrophobic and Q/N rich
regions (Kametani et al., 2016). In this report, Kametani and
co-workers found that residues 341–346 or 341–360 of the
Q/N-rich segment were protected against proteolytic cleavage,
deamidation and phosphorylation (in patient 1 and patient 2,
respectively). Although more cases are needed to confirm
whether this is indeed a general pathological feature, these
data are consistent with these segments forming an highly
stable amyloid-like structure, such as the one we have proposed
(Mompeán et al., 2015), which protects them against cleavage
and modification. In contrast, residues of the hydrophobic
segment are heavily modified by Ser phosphorylation, Gln
deamidation andMet oxidation, which suggests they are exposed
in patient aggregates. This implies that the hydrophobic segment
does not form an amyloid structure which would prevent these
modifications.
The Q/N-Rich Segment of TDP-43’s
C-Terminal Region can Quickly form a
Stable, Amyloid-Like Structure
Regarding TDP-43 aggregation, the Q/N-rich segment is
especially interesting because variants lacking it or substituting a
polyAla segment do not aggregate (Budini et al., 2012). We have
recently investigated this segment’s conformational transitions
using CD/NMR spectroscopies and computational methods.
Our studies have shown that the Q/N-rich segment is initially
FIGURE 2 | Structure and stabilizing H-bonds in the amyloid-like conformer of TDP-43 composed of residues 341–366. (A) Schematic diagram of the
beta-hairpin adopted by residues 341–357 of TDP-43. (B) Residues 358–366 could act as a loop to link different beta-hairpins in the same beta-sheet or between
different beta sheets (yellow strands and green loops). One of the two sheets of the 4X Q/N (4 hairpins) or of 12X Q/N (6 hairpins) are shown in magneta. Cooperative
and hyperpolarization effects greatly fortify Q/N side chain H-bonds (red lines) and moderately strengthen backbone H-bonds (dashed red lines) in longer 12X Q/N
assembles (right) but not the shorter 4X Q/N sheet (left). The thickness of the red lines reflects the strength of the H-bonds. (C) The formation of exceptionally stable
H-bonds provides a free energy sink which drives the binding of endogenous TDP-43 molecules to the quasi-amyloid structure formed by the 12X Q/N TDP-43
construct. The color code of the domains matches that of the sequence diagram in Figure 1 and the structures were modeled according to Mompeán et al. (2014,
2015) for the Q/N segments (magenta), Mompeán et al. (2016c) for the NTD domain (green) and Lukavsky et al. (2013) for the RRM domains (blue).
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unfolded but over the course of several hours it converts into
a structure rich in beta structure which binds thioflavin T
(Mompeán et al., 2014). This segment, modeled as a beta hairpin,
is stable in long molecular dynamics simulations. Additional
studies, using conformational antibodies specific for amyloid,
solid state NMR, X-ray diffraction and electron microscopic,
confirmed the ability of the Q/N-rich segment of TDP-43 to
adopt an amyloid-like structure, whose fibrils are broad and
tend to associate laterally, like those of polyglutamine (Mompeán
et al., 2015).
Using computational tools, we built up an amyloid-like
structural model based on beta-hairpins composed of residues
341–357 of TDP-43 arranged in parallel and with a beta-turn
topology. This arrangement was found to be stable in long
MD simulations (Figure 2). By contrast, other configurations
with consecutive beta hairpins arranged in an anti-parallel
fashion or with beta-arc topology were unstable (not shown).
Based on this model, the efficient aggregation of the 12X Q/N
TDP-43 construct in vivo suggests that these 12 repetitions
are likely to assemble into two stacked beta sheets, each
containing six beta-strands or 12 beta strands that form the
nascent, quasi-amyloid core. Residues 358–366 act as a linker
to connect 341–357 beta-hairpins and allow proper cross-beta
spine formation. This segment could connect the beta-hairpins
within each sheet, and link the two sheets, allowing them
to pack against each other (Figure 2B; Mompeán et al.,
2015).
Based on the apparent protection of residues 341–367 against
Ser phosphorylation, Gln/Asn deamidation andMet oxidation in
TDP-43 ex vivo aggregates, we therefore propose as a working
hypothesis that our conformational model for this segment
(Figure 2) may correspond to the pathological conformer
present in the ex vivo aggregates of patient 2 described by
Kametani et al. (2016). Indeed, based on the similarities
of the characteristic bands in SDS-PAGE chromatograms
previously described (Nonaka et al., 2013; Kametani et al.,
2016), our conformer may represent the structural core of
Type A TDP-43 proteinopathy, the most common class of
TDP-43 maladies (Mackenzie et al., 2011). As TDP-43 Type
A aggregates are remarkably more heat-stable as seeds than
Type B or Type C aggregates (Nonaka et al., 2013), what
remains to be addressed is the basis of this exceptional
stability. Below, we present a model that can account for
this.
Hyperpolarization-Mediated Stabilization
of Gln and Asn Side Chain Hydrogen
Bonds can Account for the Remarkable
Stability of the Putative Amyloid Formed by
the Q/N-Rich Segment of TDP-43
We have recently compared hydrogen bond cooperativity in a
Q/N-rich amyloid, the paradigmatical GNNQQNY heptapeptide
form the yeast prion Sup35, to the hydrophobic amyloid
M35VGGVV40 from Aβ (Mompeán et al., 2016b). Whereas the
backbone amide groups of both Q/N-rich and hydrophobic
amyloids experience stabilization due to hyperpolarization, an
additional and stronger type of hyperpolarization occurs in Asn
and Gln side chain amides (Figure 2B). The strengthening
due to hyperpolarization increases with the number of
strands.
According to this working hypothesis, hydrogen bond
hyperpolarization provides a very favorable free energy change
for binding monomers to the quasi-amyloid structure formed
by the Q/N-rich segment, thus permitting the TDP-43-
12X Q/N construct to efficiently sponge up endogenous
TDP-43 (Figure 2C). Hydrogen bond hypercooperativity can
also explain how the Q/N-rich subregion enables TDP-43 to
bind and co-aggregate with polyglutamine (Fuentealba et al.,
2010). As a side note, this also provides a logical explanation
for why TDP-43 12X Q/N repeats readily form a stable
amyloid capable of sequestering endogenous TDP-43 whereas
a stoichiometrically equivalent amount of Q/N repeats in
the context of 2X Q/N or 4X Q/N constructs does not
(Budini et al., 2012).
Recruitment of endogenous TDP-43 into aggregates within
this cellular model can be tentatively attributed to two different
processes. First, the tandem repetitions could form an amyloid
fold that might sponge up and sequester nuclear TDP-43 through
its Q/N segment. Second, heterodimerization via the NTDs of
endogenous TDP-43 with TDP-43-12X Q/N would increase the
local concentration of the Q/N rich segments and thereby favor
their self-association (Romano et al., 2015). In the future, more
complete structural models of TDP-43 could help determine
whether these processes act antagonistically, independently or
synergistically.
Recent studies strongly suggest that, once formed, pernicious
conformers of TDP-43 could spread through the nervous
system in a prion-like fashion (Nonaka et al., 2013; Smethurst
et al., 2015). This issue will likely prove crucial for a
better understanding of TDP-43 proteinopathies. In fact, the
aggregates’ size, location, toxicity and their stability have
been advanced as factors accounting for the efficiency of
prion-like spreading by pernicious protein aggregates (Espargaró
et al., 2016). In these conditions, the exceptional stability of
our conformer/Type A could well be pertinent to provide a
first structural framework for future studies aimed at further
elucidating this issue.
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